2011
DOI: 10.1007/s00439-011-0968-y
|View full text |Cite
|
Sign up to set email alerts
|

BMP4 loss-of-function mutations in developmental eye disorders including SHORT syndrome

Abstract: BMP4 loss-of-function mutations and deletions have been shown to be associated with ocular, digital, and brain anomalies, but due to the paucity of these reports, the full phenotypic spectrum of human BMP4 mutations is not clear. We screened 133 patients with a variety of ocular disorders for BMP4 coding region mutations or genomic deletions. BMP4 deletions were detected in two patients: a patient affected with SHORT syndrome and a patient with anterior segment anomalies along with craniofacial dysmorphism and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
108
1

Year Published

2011
2011
2019
2019

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 95 publications
(115 citation statements)
references
References 34 publications
3
108
1
Order By: Relevance
“…Prior screening by Sanger sequencing excluded mutations in PITX2 , FOXC1 , BMP4 , CYP1B1 , FOXE3 , and NDP (Reis et al. 2011, 2012, and unpublished data).…”
Section: Resultsmentioning
confidence: 68%
“…Prior screening by Sanger sequencing excluded mutations in PITX2 , FOXC1 , BMP4 , CYP1B1 , FOXE3 , and NDP (Reis et al. 2011, 2012, and unpublished data).…”
Section: Resultsmentioning
confidence: 68%
“…Patients were screened as previously described using TaqMan assays (Applied Biosystems/Life Technologies, Carlsbad, CA, USA) for the PITX2 and FOXC1 regions and/or Affymetrix Genome-Wide Human SNP Array 6.0 (Affymetrix, Santa Clara, CA, USA); 19,26 clinical Agilent 105K oligonucleotide array (Agilent Technologies, Santa Clara, CA, USA) and Affymetrix 6.0 array data were used for one patient each (cases 21 and 27, respectively). The following PITX2 probes were used for TaqMan assays: Hs00452261_cn (P1, located in the last exon of PITX2), Hs00958157_cn (P2, PITX2C promoter), Hs01402614_cn (P3, most 5' PITX2 exon, exon 1A), Hs06705585_cn (P3B, located at B50 kb upstream of PITX2), Hs04822300_cn (P4, located 110 366 kb 5' of PITX2), Hs04838001_cn (P5, located 284 481 kb 5' of PITX2), and Hs04811562_cn (P6, located 649 476 upstream of PITX2).…”
Section: Taqman Assays and Affymetrix Copy Number Analysesmentioning
confidence: 99%
“…Several previously reported polymorphisms were observed in both patient and control populations. Genomic analysis identified deletions involving the FOXC1-coding region in three probands with ARS (cases [25][26][27] as well as the case of De Hauwere syndrome (case 28) 22 (Table 2, Figure 3). Deletion size ranged from at least 0.98 Mb to at least 1.5 Mb, deleting between 2 and 11 genes.…”
Section: Foxc1 Mutations: Phenotypes and Genotypesmentioning
confidence: 99%
“…Moreover, we found that examining RNAi phenotypes at several different developmental time points and contrasting the results of maternal and zygotic knockdown studies were crucial to understanding the roles of Delta in cricket embryogenesis. Following the progression of the Dl RNAi phenotype over time allowed us to detect tissue-specific effects on neural development, as well as generic developmental delays, which are a common feature of lossof-function mutations in Notch pathway members (Ballard et al, 2010;Julian et al, 2010;Reis et al, 2011). These observations helped us to distinguish such neural and developmental delay phenotypes from specific effects on segmentation.…”
Section: Implications For the Evolution Of Segmentationmentioning
confidence: 99%